CDTX vs GD · rev $1.3M vs P/E 22, rev $52.55B
Cidara Therapeutics Inc (CDTX) versus General Dynamics Corporation (GD) — a side-by-side from cached financials, not a winner call.
Cidara Therapeutics Inc (CDTX) is a biotechnology company listed on US.
General Dynamics Corporation (GD) is a aerospace & defense company listed on US.
Latest reported CDTX revenue for 2024-12-31 was $1.3M. Net income was -$169.8M. Revenue was down 94.5% from 2023-12-31 to 2024-12-31. CDTX currently screens at market cap $6.96B.
Latest reported GD revenue for 2025-12-31 was $52.55B. Net income was $4.21B. Revenue was up 10.1% from 2024-12-31 to 2025-12-31. GD currently screens at market cap $93.69B and trailing P/E 21.8.
CDTX currently screens at market cap $6.96B. GD currently screens at market cap $93.69B and trailing P/E 21.8.
Not investment advice. Open the CDTX and GD stock pages for the full models.
Not investment advice.